Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2015 ∙ Ma, ShuJuan Li, Xing Xiong, YiQuan Yao, ALing Chen, Qing
Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety
Newborn Children Mumps Measles Rubella Varicella Efficacy/effectiveness Safety Administration
Rating:
Critically low
2015 ∙ Wang, S. Y. Cheng, X. H. Li, J. X. Li, X. Y. Zhu, F. C. Liu, P.
Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis
Western Pacific South-East Asia Newborn Children Japanese encephalitis Efficacy/effectiveness Safety
Rating:
Critically low
2015 ∙ Donken, R. de Melker, H. E. Rots, N. Y. Berbers, G. Knol, M. J.
Comparing vaccines: A systematic review of the use of the non-inferiority margin in vaccine trials
All age groups Efficacy/effectiveness
Rating:
Critically low
2015 ∙ Jin, H. Tan, Z. Zhang, X. Wang, B. Zhao, Y. Liu, P.
Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials
Adolescents Adults Older adults Healthcare workers Hepatitis B Administration Efficacy/effectiveness Safety
Rating:
Low
2015 ∙ Gonzalez-Lorenzo, M. Piatti, A. Coppola, L. Gramegna, M. Demicheli, V. Melegaro, A. Tirani, M. Parmelli, E. Auxilia, F. Moja, L.
Conceptual frameworks and key dimensions to support coverage decisions for vaccines
All age groups Acceptance Coverage Economic aspects
Rating:
Not applicable
2015 ∙ Fernandez de Casadevante, V. Gil Cuesta, J. Cantarero-Arevalo, L.
Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies
Europe Adolescents Adults Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2015 ∙ Simonella, L., Canfell, K.
Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries
All age groups Low and Middle Income Countries Human papillomavirus (HPV) Economic aspects
Rating:
Not applicable
2015 ∙ Caya, C. A. Boikos, C. Desai, S. Quach, C.
Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review
All age groups Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2015 ∙ Mariani, L. Vici, P. Suligoi, B. Checcucci-Lisi, G. Drury, R.
Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Critically low
2015 ∙ Patel, M. Pabst, L. Chattopadhyay, S. Hopkins, D. Groom, H. Myerburg, S. Morgan, J. M.
Economic review of immunization information systems to increase vaccination rates: a community guide systematic review
Americas United States of America Children Economic aspects
Rating:
Not applicable
Loading...